Topcon acquires Henson perimetry products

Article

Leading perimetry screening devices added to company’s portfolio

Topcon Healthcare has acquired the Henson line of perimetry products from Elektron Eye Technology. As part of the acquisition, members of the Elektron staff will transition to Topcon. Product manufacturing will continue to operate from the UK.

Deal terms were not disclosed, but products including Henson 9000 and 7000 are within the range of products being acquired, according to the company.

The optical perimeter, Henson 9000, is used for early glaucoma detection and ongoing monitoring of established loss. Henson 7000 is an affordable, lightweight, mobile perimeter designed to screen for suprathreshold glaucoma in the central field.

“The acquisition of the Henson range of products will provide us with the opportunity to strategically develop this area of the company’s product portfolio,” said Topcon Healthcare Marketing and Product Design Global VP John Trefethen in a statement.

Related: GenSight Biologics reports results of Lumevoq treatment on LHON patients

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.